MBX Biosciences Inc.

XNAS:MBX   4:00:00 PM EDT
31.85
+0.06 (+0.19%)
6:45:54 PM EDT: $32.03 +0.18 (+0.57%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

MBX Biosciences Inc. Stock, XNAS:MBX

11711 North Meridian Street, Suite 300, Carmel, Indiana 46032
United States of America
Phone: +1.317.659.0200
Number of Employees: 43
http://www.mbxbio.com

Description

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.